Research published in Cell Reports identifies that medulloblastoma cells can spontaneously differentiate into a non-cancerous state similar to normal brain development. This study highlights the transcription factor NeuroD1 as the primary driver of this transformation, which strips the cells of their ability to divide and form tumors. In most malignant cells, NeuroD1 is epigenetically silenced by the enzyme EZH2 through specific histone methylation. Consequently, the researchers found that using EZH2 inhibitors can force these tumor cells to mature into differentiated neurons. This therapeutic approach offers a promising way to repress tumor growth by bypassing traditional toxic treatments. Ultimately, the findings suggest that stimulating cellular differentiation could be a powerful strategy for treating aggressive brain cancers.

References:

• Cheng Y, Liao S, Xu G, et al. NeuroD1 dictates tumor cell differentiation in medulloblastoma[J]. Cell reports, 2020, 31(12).